» Articles » PMID: 11358591

Growth Potential of Female Prolactinomas

Overview
Journal Surg Neurol
Specialty Neurosurgery
Date 2001 May 19
PMID 11358591
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The indications for treatment in female patients with small prolactinomas and mild or no symptoms are controversial. The aim of this study was to investigate whether we can predict the growth potential of a given small prolactinoma.

Methods: The proliferation potential of 25 female prolactinomas and 5 prolactin-containing adenomas found incidentally at autopsy was determined immunohistochemically using the Ki-67 (MIB-1) antibody. The results were compared according to age, clinical and endocrine findings, and tumor volume.

Results: Small prolactinomas (<1.0 cm(3)) with mild hyperprolactinemia (<150 ng/mL) showed significantly low proliferation potential irrespective of age, resembling prolactin-containing adenomas found at autopsy. The patients tended to present with mild symptoms and rarely had estrogen deficiency.

Conclusion: These findings indicate that female patients with a small prolactinoma, mild hyperprolactinemia, and no symptoms or those who do not desire fertility may have no specific reason for treatment, but can be followed by serum prolactin level and serial magnetic resonance imaging.

Citing Articles

Gender Differences in Patients with Prolactinoma: Single-center Ukrainian Experience.

Voznyak O, Zinkevych I, Lytvynenko A, Hryniv N, Ilyuk R, Kobyliak N Rev Recent Clin Trials. 2024; 19(3):204-214.

PMID: 38561622 DOI: 10.2174/0115748871288948240325080936.


Prolactinoma through the female life cycle.

Eschler D, Javanmard P, Cox K, Geer E Endocrine. 2017; 59(1):16-29.

PMID: 29177641 DOI: 10.1007/s12020-017-1438-7.


A novel "total pituitary hormone index" as an indicator of postoperative pituitary function in patients undergoing resection of pituitary adenomas.

Wang S, Li B, Ding C, Xiao D, Wei L Oncotarget. 2017; 8(45):79111-79125.

PMID: 29108291 PMC: 5668024. DOI: 10.18632/oncotarget.15978.


Clinicopathological Features of Growth Hormone-Producing Pituitary Adenomas in 242 Acromegaly Patients: Classification according to Hormone Production and Cytokeratin Distribution.

Mori R, Inoshita N, Takahashi-Fujigasaki J, Joki T, Nishioka H, Abe T ISRN Endocrinol. 2013; 2013:723432.

PMID: 23401791 PMC: 3563234. DOI: 10.1155/2013/723432.


How to investigate and treat: headache and hyperprolactinemia.

Bussone G, Usai S, Moschiano F Curr Pain Headache Rep. 2012; 16(4):365-70.

PMID: 22639180 DOI: 10.1007/s11916-012-0267-x.